-+ 0.00%
-+ 0.00%
-+ 0.00%

OLEMA PHARMACEUTICALS INC - STUDY TO EVALUATE OP-3,136 AND DAROLUTAMIDE IN 36 PATIENTS, INITIATION EXPECTED IN H2 2026

Reuters·05/26/2026 11:00:01

Please log in to view news